Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

205 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
What nanomedicine in the clinic right now really forms nanoparticles?
Svenson S. Svenson S. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Mar-Apr;6(2):125-35. doi: 10.1002/wnan.1257. Epub 2014 Jan 10. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014. PMID: 24415653
Theranostics: are we there yet?
Svenson S. Svenson S. Mol Pharm. 2013 Mar 4;10(3):848-56. doi: 10.1021/mp300644n. Epub 2013 Feb 4. Mol Pharm. 2013. PMID: 23379301 Review.
Dendrimers for enhanced drug solubilization.
Svenson S, Chauhan AS. Svenson S, et al. Nanomedicine (Lond). 2008 Oct;3(5):679-702. doi: 10.2217/17435889.3.5.679. Nanomedicine (Lond). 2008. PMID: 18817470 Review.
The dendrimer paradox--high medical expectations but poor clinical translation.
Svenson S. Svenson S. Chem Soc Rev. 2015 Jun 21;44(12):4131-44. doi: 10.1039/c5cs00288e. Chem Soc Rev. 2015. PMID: 25971933 Review.
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
Svenson S, Case RI, Cole RO, Hwang J, Kabir SR, Lazarus D, Lim Soo P, Ng PS, Peters C, Shum P, Sweryda-Krawiec B, Tripathi S, van der Poll D, Eliasof S. Svenson S, et al. Mol Pharm. 2016 Mar 7;13(3):737-47. doi: 10.1021/acs.molpharmaceut.5b00608. Epub 2016 Feb 2. Mol Pharm. 2016. PMID: 26835715
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.
Svenson S, Wolfgang M, Hwang J, Ryan J, Eliasof S. Svenson S, et al. J Control Release. 2011 Jul 15;153(1):49-55. doi: 10.1016/j.jconrel.2011.03.007. Epub 2011 Mar 23. J Control Release. 2011. PMID: 21406204
Dendrimers as versatile platform in drug delivery applications.
Svenson S. Svenson S. Eur J Pharm Biopharm. 2009 Mar;71(3):445-62. doi: 10.1016/j.ejpb.2008.09.023. Epub 2008 Oct 17. Eur J Pharm Biopharm. 2009. PMID: 18976707 Review.
Dendrimers in biomedical applications--reflections on the field.
Svenson S, Tomalia DA. Svenson S, et al. Adv Drug Deliv Rev. 2005 Dec 14;57(15):2106-29. doi: 10.1016/j.addr.2005.09.018. Epub 2005 Nov 21. Adv Drug Deliv Rev. 2005. PMID: 16305813 Review.
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
Tomalia DA, Reyna LA, Svenson S. Tomalia DA, et al. Among authors: svenson s. Biochem Soc Trans. 2007 Feb;35(Pt 1):61-7. doi: 10.1042/BST0350061. Biochem Soc Trans. 2007. PMID: 17233602
Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin-PEG Copolymer Based Delivery Platform.
Metcalf CA 3rd, Svenson S, Hwang J, Tripathi S, Gangal G, Kabir S, Lazarus D, Cole R, Sweryda-Krawiec B, Shum P, Brown D, Case RI, van der Poll D, Rohde E, Harlfinger S, Teng CH, Eliasof S. Metcalf CA 3rd, et al. Among authors: svenson s. J Med Chem. 2019 Nov 14;62(21):9541-9559. doi: 10.1021/acs.jmedchem.9b00892. Epub 2019 Oct 24. J Med Chem. 2019. PMID: 31593466
205 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback